TwinBeech Capital’s Roivant Sciences ROIV Stock Holding History

TwinBeech Capital’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-306,051	Closed	-$3.23M	–	854
2024 Q2	$3.23M	Sell	306,051 -17,315	-5%	-$190K	0.06%	275
2024 Q1	$3.41M	Buy	323,366 +309,414	+2,218%	+$3.34M	0.07%	269
2023 Q4	$157K	Buy	+13,952	New	+$136K	﹤0.01%	606
2023 Q2	–	Sell	-10,970	Closed	-$81K	–	818
2023 Q1	$81K	Buy	+10,970	New	+$90.3K	﹤0.01%	571

Other funds holding ROIV

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PSC

Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

TwinBeech Capital's ROIV Position: Q3 2024 in Review

TwinBeech Capital sold out of Roivant Sciences (ROIV) in Q3 2024, closing a stake of 306,051 shares — an estimated $3.23M sold.

TwinBeech Capital first reported a position in ROIV in Q1 2023 and held it in 4 quarters. The position peaked at $3.41M in Q1 2024. 293 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

TwinBeech Capital reported no remaining Roivant Sciences position as of Q3 2024 after selling out during the quarter.
TwinBeech Capital sold 306,051 Roivant Sciences shares in Q3 2024, an estimated $3.23M.
TwinBeech Capital first reported a position in Roivant Sciences in Q1 2023 and held it in 4 quarters.
TwinBeech Capital's Roivant Sciences position peaked at $3.41M in Q1 2024.
293 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on TwinBeech Capital's 13F filing for Q3 2024, filed 14 Nov 2024.